Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousHematopoietic Stem Cell MobilizationTransplantation ConditioningBone Marrow TransplantationGraft vs Host DiseaseStem Cell TransplantationHematologic NeoplasmsLeukapheresisGranulocyte Colony-Stimulating FactorMelphalanAntigens, CD34Blood Component RemovalGraft SurvivalCombined Modality TherapyCyclophosphamideHematopoietic Stem CellsBusulfanTreatment OutcomeMyeloablative AgonistsMultiple MyelomaTissue DonorsAntineoplastic Combined Chemotherapy ProtocolsStem CellsTransplantation ChimeraCord Blood Stem Cell TransplantationRecurrenceBone MarrowWhole-Body IrradiationRemission InductionLymphoma, Non-HodgkinHistocompatibilityHistocompatibility TestingAntineoplastic Agents, AlkylatingEtoposideImmunosuppressive AgentsLeukemiaThiotepaPOEMS SyndromeTransplantation, IsogeneicDisease-Free SurvivalRetrospective StudiesInfectionHematopoiesisBone Marrow CellsVidarabineSurvival AnalysisAnemia, AplasticSurvival RateCytomegalovirus InfectionsTime FactorsLeukemia, Myeloid, AcuteSalvage TherapyAmyloidosisBlood CellsHodgkin DiseaseGraft vs Leukemia EffectIfosfamideVincristineCytarabineCarmustinePlatelet CountMyelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveOpportunistic InfectionsLymphocyte DepletionCyclosporineFatal OutcomeImmunosuppressionLymphomaKidney TransplantationBlood Cell CountPrecursor Cell Lymphoblastic Leukemia-LymphomaHematologic DiseasesFollow-Up StudiesHLA AntigensNeoplasmsBone Marrow PurgingLiver TransplantationCytophagocytosisBone Marrow DiseasesFeasibility StudiesHistiocytosis, Non-Langerhans-CellImmunophenotypingBlood DonorsLivedo ReticularisProspective StudiesDoxorubicinRecombinant ProteinsBlood Group IncompatibilityMesenchymal Stem Cell TransplantationPrednisoneTransplantation ImmunologyPilot ProjectsT-LymphocytesAcute DiseasePrognosisLeukocyte Count